Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3481 AL 3495

Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy

Planetta PJ, Kurani AS, Shukla P, Prodoehl J, Corcos DM, Comella CL, McFarland NR, Okun MS, Vaillancourt DE.

Hum Brain Mapp. 2015 Mar;36(3):1165-79. doi: 10.1002/hbm.22694. Epub 2014 Nov 21.

Motor switching and motor adaptation deficits contribute to freezing of gait in Parkinson's disease

Mohammadi F, Bruijn SM, Vervoort G, van Wegen EE, Kwakkel G, Verschueren S, Nieuwboer A.

Neurorehabil Neural Repair. 2015 Feb;29(2):132-42. doi: 10.1177/1545968314545175. Epub 2014 Nov 21.

A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism

Keogh MJ, Daud D, Pyle A, Duff J, Griffin H, He L, Alston CL, Steele H, Taggart S, Basu AP, Taylor RW, Horvath R, Ramesh V, Chinnery PF.

Neurogenetics. 2015 Jan;16(1):65-7. doi: 10.1007/s10048-014-0431-z. Epub 2014 Nov 25.

Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation

Krishan S, Richardson DR, Sahni S.

Mol Pharmacol. 2015;87(3):363-77. doi: 10.1124/mol.114.095810. Epub 2014 Nov 24.

Parkinson's Disease-Related Impairments in Body Movement, Coordination and Postural Control Mechanisms When Performing 80° Lateral Gaze Shifts

Bonnet CT, Delval A, Defebvre L.

IEEE Trans Neural Syst Rehabil Eng. 2015 Sep;23(5):849-56. doi: 10.1109/TNSRE.2014.2369455. Epub 2014 Nov 20.

What has fluorescent sensing told us about copper and brain malfunction?

Shen C, New EJ.

Metallomics. 2015 Jan;7(1):56-65. doi: 10.1039/c4mt00288a. Epub 2014 Nov 26.

Physical therapist interventions for Parkinson disease

Gisbert R, Schenkman M.

Phys Ther. 2015 Mar;95(3):299-305. doi: 10.2522/ptj.20130334. Epub 2014 Nov 25.

Cognition enhancers for the treatment of dementia

Malek N, Greene J.

Scott Med J. 2015 Feb;60(1):44-9. doi: 10.1177/0036933014561948. Epub 2014 Nov 27.

Overview on the biotechnological production of L-DOPA

Min K, Park K, Park DH, Yoo YJ.

Appl Microbiol Biotechnol. 2015 Jan;99(2):575-84. doi: 10.1007/s00253-014-6215-4. Epub 2014 Nov 30.

Are sleep disturbances preclinical markers of Parkinson's disease?

dos Santos AB, Kohlmeier KA, Barreto GE.

Neurochem Res. 2015 Mar;40(3):421-7. doi: 10.1007/s11064-014-1488-7. Epub 2014 Nov 30.

Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study

Vallabhajosula S, Haq IU, Hwynn N, Oyama G, Okun M, Tillman MD, Hass CJ.

Brain Stimul. 2015 Jan-Feb;8(1):64-75. doi: 10.1016/j.brs.2014.10.011. Epub 2014 Oct 28.

Neurogenetic disorders in the Basque population

Martí Massó JF, Zarranz JJ, Otaegui D, López de Munain A.

Ann Hum Genet. 2015 Jan;79(1):57-75. doi: 10.1111/ahg.12088. Epub 2014 Dec 1.

Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease

Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Pasqualetti P, Peppe A.

Parkinsonism Relat Disord. 2015 Feb;21(2):95-100. doi: 10.1016/j.parkreldis.2014.11.002. Epub 2014 Nov 14.

The nicotinic cholinergic system function in the human brain

Nees F.

Neuropharmacology. 2015 Sep;96(Pt B):289-301. doi: 10.1016/j.neuropharm.2014.10.021. Epub 2014 Nov 6.

The therapeutic potential of interleukin-10 in neuroimmune diseases

Kwilasz AJ, Grace PM, Serbedzija P, Maier SF, Watkins LR.

Neuropharmacology. 2015 Sep;96(Pt A):55-69. doi: 10.1016/j.neuropharm.2014.10.020. Epub 2014 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias